Abstract:We first discovered that HIPK2 was down-regulated in insulin-resistant population through PPARγ pathway. Homeodomain interacting protein kinase 2 (HIPK2), the highly conserved nuclear serine/threonine kinase, is known to act as a co-repressor through interacting with a number of transcription factors. Notably, HIPK2 inhibits cell growth through the activation of p53. However, its in vivo function in insulin resistance is still unknown. Recently, the discovery by Sjolund et al.1 has implicated HIPK2 as a central modulator of adipogenesis. They found that deletion of HIPK2 in mice gave rise to decreased adipogenesis and increased insulin-sensitivity independence of the peroxisome proliferator-activated receptor gamma (PPARγ) signaling pathway. According to their result, we hypothesize that the expression of HIPK2 in the insulin-resistant population might be upregulated. To testify our supposition, we analyzed the publicly available expression data from two human insulin-resistant expression data in GEO datasets that use the same platform. Contrary to our deduction, the HIPK2 gene was downregulated in the insulin-resistant population (Figure 1a,b). PPARγ is the key transcription factor in adipogenesis, as well as glucose and fatty acid metabolism, and alterations in the pathway lead to insulin resistance and type 2 diabetes mellitus2. According to the report by Sjolund et al.1, the function of HIPK2 was not mediated by a PPARγ-dependent mechanism1. However, we identified that some downstream targets of PPARγ, which Sjolund et al. mentioned, were downregulated in adipocytes in insulin-resistant people, which is synchronously expressed with HIPK2 messenger ribonucleic acid expression (Figure 1c). Some transcription cofactors of PPARγ shown by GeneMANIA (http://www.genemania.org/) were also downregulated in the adipocytes of the insulin-resistant population (Figure 1d). Rosiglitazone (Rosi), a member of the thiazolidinediones and an agonist of PPARγ, works as an insulin sensitizer in type 2 diabetes mellitus3. The present results showed that HIPK2 messenger ribonucleic acid expression was significantly increased in the presence of both Rosi and overexpressed PPARγ in murine marrow-derived U-33 cells, indicating a tendency of increased HIPK2 expression after administration of insulin sensitizer (Figure 1e). In agreement with this, several other articles published the same results that HIPK2 expression was elevated after administration of insulin sensitizer, rosiglitazone and troglitazone (Table S1), suggested by The Comparative Toxicogenomics Database (http://ctdbase.org/). Taken together, despite of Sjolund et al. discovery that HIPK2 deletion in mice induces increased insulin sensitivity and was not mediated by the PPARγ pathway, our data suggest that downexpression of HIPK2 was discovered in a population that suffered from decreased insulin sensitivity (insulin resistance) through the PPARγ-dependent pathway. This discrepancy might be caused by the following reasons: (i) metabolic differences between humans and murine; (ii) the discovery by Sjolund et al. was carried out on skeletal muscle, where the present results were shown in adipocytes; and (iii) our discovery was the result of a subset of humans, accordingly, the discovery by Sjolund et al. was based on a few HIPK2 knockout mice, the two studies all await further verification. Furthermore, we also showed that administration of insulin sensitizer could promote the elevated expression of HIPK2, thus providing a benefit for treatment of insulin resistance. This work was supported by the National Natural Science Foundation of China (81471427). The authors declare no conflict of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Homeodomain Interacting Protein Kinase2 is Downregulated Through the Peroxisome Proliferator-Activated Receptor Gamma Signaling Pathway in an Insulin-Resistant Population

11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes

Down-regulation of Hepatic HNF4alpha Gene Expression During Hyperinsulinemia Via SREBPs.

Serum- and glucocorticoid-inducible kinase 1 promotes insulin resistance in adipocytes via degradation of insulin receptor substrate 1

Pyruvate dehydrogenase kinase 1 and 2 deficiency reduces high-fat diet-induced hypertrophic obesity and inhibits the differentiation of preadipocytes into mature adipocytes

PKB/Akt phosphorylation of ERRγ contributes to insulin-mediated inhibition of hepatic gluconeogenesis

Homeodomain-interacting Protein Kinase 2 Suppresses Proliferation and Aerobic Glycolysis Via ERK/cMyc Axis in Pancreatic Cancer

Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4

Protein kinase D2 modulates hepatic insulin sensitivity in male mice

Involvement of Inducible 6-Phosphofructo-2-kinase in the Anti-diabetic Effect of Peroxisome Proliferator-activated Receptor Γ Activation in Mice

HIPK2 Overexpression Relieves Hypoxia/reoxygenation-Induced Apoptosis and Oxidative Damage of Cardiomyocytes Through Enhancement of the Nrf2/ARE Signaling Pathway.

Adipose depot-specific upregulation of Ucp1 or mitochondrial oxidative complex proteins are early consequences of genetic insulin reduction in mice

Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.

Hepatic serum- and glucocorticoid-regulated protein kinase 1 (SGK1) regulates insulin sensitivity in mice via extracellular-signal-regulated kinase 1/2 (ERK1/2).

Molecular Mechanism of Insulin Resistance and Obesity

Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue

Insulin Decreases Myocardial Adiponectin Receptor 1 Expression Via PI3K/Akt and FoxO1 Pathway.

HIPK2 Overexpression Leads to Stabilization of P53 Protein and Increased P53 Transcriptional Activity by Decreasing Mdm2 Protein Levels

1303-P: Decreased Hepatic HMGB1 in Type 2 Diabetes Increases Mitochondrial Glucose Uptake by Regulating Insulin/AKT Signaling

Role of serum- and glucocorticoid-inducible kinase 1 in the regulation of hepatic gluconeogenesis.

Hypoxia in 3T3-L1 Adipocytes Suppresses Adiponectin Expression Via the PERK and IRE1 Unfolded Protein Response.